ATE214423T1 - B-lymphomazellinie und antigen - Google Patents

B-lymphomazellinie und antigen

Info

Publication number
ATE214423T1
ATE214423T1 AT93920252T AT93920252T ATE214423T1 AT E214423 T1 ATE214423 T1 AT E214423T1 AT 93920252 T AT93920252 T AT 93920252T AT 93920252 T AT93920252 T AT 93920252T AT E214423 T1 ATE214423 T1 AT E214423T1
Authority
AT
Austria
Prior art keywords
antigen
cell
cell line
detecting
provides
Prior art date
Application number
AT93920252T
Other languages
English (en)
Inventor
Glenn H Bock
David L Nelson
Carole C Kurman
Thomas A Fleisher
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE214423T1 publication Critical patent/ATE214423T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3061—Blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT93920252T 1992-08-21 1993-08-20 B-lymphomazellinie und antigen ATE214423T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93410692A 1992-08-21 1992-08-21
PCT/US1993/007856 WO1994004659A1 (en) 1992-08-21 1993-08-20 A novel b-lymphoma cell line and antigen

Publications (1)

Publication Number Publication Date
ATE214423T1 true ATE214423T1 (de) 2002-03-15

Family

ID=25464975

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93920252T ATE214423T1 (de) 1992-08-21 1993-08-20 B-lymphomazellinie und antigen

Country Status (8)

Country Link
US (1) US5556947A (de)
EP (1) EP0672118B1 (de)
JP (1) JPH08503603A (de)
AT (1) ATE214423T1 (de)
AU (1) AU678399B2 (de)
CA (1) CA2142989A1 (de)
DE (1) DE69331703D1 (de)
WO (1) WO1994004659A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012503A1 (en) * 1994-10-21 1996-05-02 Chugai Seiyaku Kabushiki Kaisha Remedy for diseases caused by il-6 production
RU2197011C2 (ru) * 2000-12-26 2003-01-20 Открытое акционерное общество "Холдинговая компания "Тасма" Способ усиления серебряного изображения на радиографических материалах
AU2003218049A1 (en) * 2002-02-27 2003-09-09 University Of South Carolina Targeted immunotherapy of acute lymphoblastic leukemia (all)
AU2003245317A1 (en) * 2002-05-20 2003-12-12 The Government Of The United States Of America As Represented By The Secretary, Department Of Health Elisa assay of serum soluble cd22 to assess tumor burden/relapse in subjects with leukemia and lymphoma
US6916259B2 (en) * 2002-08-01 2005-07-12 Stx, Llc Lacrosse head having an articulated member
US8252286B2 (en) * 2007-05-21 2012-08-28 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
KR101741731B1 (ko) 2007-05-21 2017-05-30 앨더바이오 홀딩스 엘엘씨 Ｉｌ-６에 대한 항체 및 이의 용도
KR20170036814A (ko) * 2007-05-21 2017-04-03 앨더바이오 홀딩스 엘엘씨 신규한 래빗 항체 인간화 방법 및 인간화된 래빗 항체
US9701747B2 (en) 2007-05-21 2017-07-11 Alderbio Holdings Llc Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
US8062864B2 (en) 2007-05-21 2011-11-22 Alderbio Holdings Llc Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
US7906117B2 (en) * 2007-05-21 2011-03-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
US8178101B2 (en) * 2007-05-21 2012-05-15 Alderbio Holdings Inc. Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
US8404235B2 (en) 2007-05-21 2013-03-26 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US20090238825A1 (en) * 2007-05-21 2009-09-24 Kovacevich Brian R Novel rabbit antibody humanization methods and humanized rabbit antibodies
US20090111618A1 (en) * 2007-10-30 2009-04-30 Warrior Sports, Inc. Lacrosse box goalie head
US9212223B2 (en) 2008-11-25 2015-12-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US8420089B2 (en) 2008-11-25 2013-04-16 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US8323649B2 (en) 2008-11-25 2012-12-04 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
US9452227B2 (en) * 2008-11-25 2016-09-27 Alderbio Holdings Llc Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
US8992920B2 (en) 2008-11-25 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of arthritis
US8337847B2 (en) 2008-11-25 2012-12-25 Alderbio Holdings Llc Methods of treating anemia using anti-IL-6 antibodies
CN102630155B (zh) * 2009-09-18 2015-11-25 拜欧米特公司 一次性整形外科手术套件和部件
CN102740888B (zh) 2009-11-24 2016-10-12 奥尔德生物制药公司 Il-6抗体及其用途
US9775921B2 (en) 2009-11-24 2017-10-03 Alderbio Holdings Llc Subcutaneously administrable composition containing anti-IL-6 antibody
US8992908B2 (en) 2010-11-23 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of oral mucositis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030072751A1 (en) * 1990-03-14 2003-04-17 Heribert Bohlen Idiotypic vaccination against b cell lymphoma

Also Published As

Publication number Publication date
CA2142989A1 (en) 1994-03-03
JPH08503603A (ja) 1996-04-23
DE69331703D1 (de) 2002-04-18
EP0672118A1 (de) 1995-09-20
EP0672118B1 (de) 2002-03-13
WO1994004659A1 (en) 1994-03-03
AU678399B2 (en) 1997-05-29
AU5084493A (en) 1994-03-15
US5556947A (en) 1996-09-17

Similar Documents

Publication Publication Date Title
ATE214423T1 (de) B-lymphomazellinie und antigen
DE69028684D1 (de) Gegen die beta-kette des leukozyten-adhäsions-rezeptors gerichtete monoklonale antikörper, verfahren zu ihrer herstellung und ihre verwendung
MY104946A (en) Antigen antibody conjugate.
ATE171461T1 (de) Immunstimulierende monoklonale antikörper
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
AR243931A1 (es) Antigeno purificado,conjunto de reactivos para la deteccion de anticuerpos anti-hiv-2 en un fluido biologico que comprende dichos antigenos,anticuerpos,hibridomas y procedimientos.
ZA946767B (en) Monocional antibodies having property of causing apoptosis.
ES551496A0 (es) Procedimiento de obtencion de un anticuerpo monoclonal reactivo con antigenos de esporozoitos de eimeria spp.
GB8504104D0 (en) Hcmv monoclonal antibodies
ES551495A0 (es) Procedimiento de obtencion de un anticuerpo monoclonal reactivo con antigenos de esporozoitos o merozoitos de eimeria spp.
DK0840620T3 (da) IL-8-antagonister til behandling af astma
IL68752A (en) Human hybridomas cell lines producing monoclonal antibodies capable of distinguishing neoplastic cells from normal cells,antibodies produced by them and method for determining the presence of a neoplasm by using said antibodies
YU46858B (sh) Postupak za dobijanje imunoglobulinskih konjugata
CA2132213A1 (en) Specific detection of cell surface receptor leukocyte adhesion molecule-1
ES8606662A1 (es) Un metodo de evaluar la actividad activadora de macrofagos de una solucion o mezcla
DE3580482D1 (de) Monoklonale antikoerper und immunisierung damit.
EP0554458A4 (en) Immunoassay, monoclonal antibody and hybridoma
DK24891A (da) Monoklonalt antistof til inhibering af cellers infektion med hiv-vira
AU8547291A (en) Monoclonal antibodies against tenascin
IE882250L (en) Monoclonal antibodies and methods for diagnosis of Phytophthora infection
TW288020B (en) Monoclonal antibodies specific to methamphetamine, hybridoma producing the antibodies, kits containing the antibodies and uses thereof
EP0369797A3 (de) Moloklonaler Antikörper, der die Reg-Proteine erkennt
IT8821702A0 (it) Nuovo anticorpo monoclonale.
BE904811A (fr) Anticorps monoclonaux.
ATE130856T1 (de) Menschlicher monoklonaler antikörper gegen candida.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties